At the 2014 World Drug Safety Congress Americas, Anne Wolka, Eli Lilly and Company, gave a presentation on “New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment”.
Download and learn:
- The rebirth of the PSUR
- Objective of the PBRER
- Critical Analysis of Benefits
- Critical Analysis of Risks
- Integrated Benefit-Risk Analysis
- Impact of the PBRER
- So What Is a Structured Approach to Benefit-Risk Assessment?
- Frameworks for Benefit-Risk Assessment
- The Big Picture
Found this interesting? Join us in 2015 for the 7th annual World Drug Safety Congress Americas conference. The conference will address improving patient safety strategies, new technology applications in drug safety and will offer the most innovative and freshest case studies on current drug safety projects.